Scientific Reports (Aug 2023)

Potential of circulating receptor-interacting protein kinase 3 levels as a marker of acute liver injury

  • Takayuki Kondo,
  • Kentaro Fujimoto,
  • Kisako Fujiwara,
  • Sae Yumita,
  • Takamasa Ishino,
  • Keita Ogawa,
  • Miyuki Nakagawa,
  • Terunao Iwanaga,
  • Keisuke Koroki,
  • Hiroaki Kanzaki,
  • Masanori Inoue,
  • Kazufumi Kobayashi,
  • Soichiro Kiyono,
  • Masato Nakamura,
  • Naoya Kanogawa,
  • Sadahisa Ogasawara,
  • Shingo Nakamoto,
  • Tetsuhiro Chiba,
  • Jun Kato,
  • Keiichi Fujiwara,
  • Naoya Kato

DOI
https://doi.org/10.1038/s41598-023-41425-6
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 10

Abstract

Read online

Abstract The pathogenesis of acute liver failure (ALF) involves cell death. Necroptosis is a newly suggested programmed cell death, and receptor-interacting protein kinase 3 (RIPK3) has been reported as a marker for necroptosis. However, there are few reports on necroptosis in ALF. Therefore, we evaluated the role of cell death markers such as cytokeratin (CK) 18, cleaved CK (cCK) 18, and RIPK3 in ALF, as well as cytokines and hepatocyte growth factor (HGF). Seventy-one hospitalized patients with acute liver injury (38 nonsevere hepatitis [non-SH]/22 severe hepatitis [SH]/11 ALF) were studied. No significant difference was found for cytokines, but a substantial increase in HGF levels was found following the severity of hepatitis. The non-SH group had lower levels of CK18 and cCK18 than the SH/ALF group. RIPK3 was significantly lower in the non-SH/SH group than in the ALF group. HGF, RIPK3, and albumin levels were found to be important predictive variables. The present study suggests that cCK18, CK18, and RIPK3 are associated with the severity of hepatitis. RIPK3 and other markers related cell death may be useful for understanding the pathogenesis of ALF and as a prognostic marker of acute liver injury.